Canakinumab: Promising Drug Being Developed for Systemic Juvenile

Canakinumab: Promising Drug Being Developed for Systemic Juvenile

Filed under: drug treatment news 2012

The drug also delayed the recurrence of flares and allowed the SIJA patients to substantially reduce or discontinue the use of corticosteroids. Despite known side effects and because treatment options are limited, corticosteroids have commonly been …
Read more on About – News & Issues

 

Route to growth lies in tax cuts

Filed under: drug treatment news 2012

There are arguments that it would be logical to legalise prostitution and certain recreational drugs but then tax them heavily. Such tax burdens may reduce demand, bring these activities into the light of day and make controls and treatment of abuse …
Read more on BusinessLIVE

 

Alexza's inhaled drug for schizophrenia, bipolar disorder gets FDA OK

Filed under: drug treatment news 2012

Dec 21 (Reuters) – Alexza Pharmaceuticals Inc said the U.S. health regulators approved Adasuve, making it the first treatment for schizophrenia and bipolar disorder that can be inhaled. Adasuve, which delivers an older antipsychotic drug called …
Read more on MedCity News